TNT achieved a 93.7% complete response rate and 87.5% organ preservation in stage I rectal cancer patients. TNT may offer an organ-preserving alternative to surgery, especially for low-lying tumors, ...
All patients diagnosed with early-onset colorectal cancer (EOCRC) should undergo germline multigene panel testing, as recommended by current National Comprehensive Cancer Network guidelines, to inform ...
Neoadjuvant therapy with immunotherapy in pMMR/MSS rectal cancer shows high response rates and favorable surgical outcomes, with manageable safety profiles. Short-course chemoradiotherapy demonstrates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results